Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CounterPoint Capital Management is a private equity firm headquartered in Los Angeles, California, that specializes in control investments in lower-middle market companies. The firm focuses on "complex situations," including corporate carve-outs, restructurings, and turnaround opportunities across various industries, with a significant historical emphasis on the healthcare and life sciences sectors. CounterPoint provides both capital and operational expertise to its portfolio companies to drive growth and operational efficiency. In the healthcare space, the firm has targeted businesses involved in medical device manufacturing, healthcare services, and specialty distribution. One of its most notable involvements was the acquisition and subsequent growth of MedPlast, which evolved into the major medical device contract manufacturing organization (CDMO) known as Viant.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CounterPoint Capital Management.